Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Herold KC, Bundy BN, Long SA, Bluestone JA, et al. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019 Jun 9. doi: 10.1056/NEJMoa1902226.
PMID: 31180194


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016